Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1-Reference-Cited by-同舟云学术

Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1

Published:2023-03 Issue: Volume:28 Page:334-348
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Chouljenko Dmitry V.^ORCID,Murad Yanal M.,Lee I-Fang,Delwar Zahid,Ding Jun,Liu Guoyu,Liu Xiaohu,Bu Xuexian,Sun Yi,Samudio Ismael,Jia William Wei-Guo

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference63 articles.

1. A review of cancer immunotherapy toxicity;Kennedy;CA. Cancer J. Clin.,2020

2. A review of cancer immunotherapy toxicity: immune checkpoint inhibitors;Chhabra;J. Med. Toxicol.,2021

3. A review of cancer immunotherapy toxicity II: adoptive cellular therapies, kinase inhibitors, monoclonal antibodies, and oncolytic viruses;Chhabra;J. Med. Toxicol.,2022

4. CAR-T cells and oncolytic viruses: joining forces to overcome the solid tumor challenge;Guedan;Front. Immunol.,2018

5. Development of oncolytic viruses for cancer therapy;Abd-Aziz;Transl. Res.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and research progress of oncolytic virus;Pharmaceutical Science Advances;2024-12

2. Immunotherapy for colorectal cancer;Frontiers in Immunology;2024-08-21

3. miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses;Pharmaceutics;2024-07-25

4. Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?;Journal for ImmunoTherapy of Cancer;2024-05

5. Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells;Vaccines;2023-12-02